Jennifer Bowman, Director, leads strategic client engagements focused primarily on the Medicare prescription drug benefit.  Jen has expertise in Medicare policy, policy analysis, the legislative and regulatory process, and strategic consulting.  

Jen leads strategic client engagements on behalf of Fortune 500 pharmaceutical and biotechnology clients and patient advocacy groups focused on the implementation of the Medicare prescription drug benefit.  Her projects involve analyzing legislation, regulations and guidance documents, and helping clients determine the impact of those changes on their business strategies.  Jen also leads research projects that are sponsored by nonprofit foundations and published in peer-reviewed journals.

Jen was a health analyst with the Congressional Budget Office (CBO) from 1999 to 2002, where she focused on developing estimates of the cost impact of legislation on health plans.  She is a contributing author on a number of CBO publications, including cost estimates, studies, and congressional testimony.

Jen earned a M.P.H. in Health Policy from Yale University and a B.A. in Biochemistry from Rice University.